WHO has recommends that stop using remdesivir in COVID-19 treatment because of no evidence that its use has been shown to improve the patient’s physical condition or reduce the risk of death.
This was suggested by a panel of the World Health Organization (WHO) on Friday.
“The WHO’s panel did not find sufficient evidence to reduce the patient’s risk of death, reduce the need for ventilation, speed up recovery or any other benefit,” they said.
One of the two drugs that have recently been approved for the treatment of Covid-19 is remdesivir.
But last month the World Health Organization expressed its opinion about a clinical trial on the effects of remdesivir produced by Gilead Sciences Inc. in the United States.
Researchers at the agency said in their study that the drugs had little or no effect on reducing hospital stays or deaths in patients admitted to the hospital with Covid-19.
The trial was conducted on 11,266 patients from more than 30 countries around the world.
In addition to remdesivir, the trials tested the efficacy of hydroxychloroquine, the anti-AIDS lopinavir/ritonavir and interferon.
Gilead has questioned the WHO’s trial. Gilead authorities said in a statement: “Treatment of Covid-19 patients hospitalized by a world-renowned pharmaceutical company has recognized our VCLURI (brand name for Remedicivir made in Gilead) as a quality treatment system.
“We are very disappointed with the WHO’s guidance as the number of Covid-19 infections in the world continues to rise dramatically and physicians are relying on Veclori as the first and only approved antiviral drug to treat the disease. The agency is ignoring all evidence from other drug regulators. ”
The United States has said in April that it had “clear” evidence of a supportive role for Remedicivir.
Later in May, the United States Food and Drug Administration (FDA) received emergency approval from Remedicevir; Since then various countries have started using this medicine, which is made to prevent Ebola in the treatment of Covid-19 patients.
Remdesivir treatment is also used when US President Donald Trump is infected with Covid-19.